7.85
-0.07
(-0.83%)
As of 8:09:48 AM GMT+2. Market Open.
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Operating Cash Flow
-35,614
-30,812
-27,785
-24,238
-30,384
Financing Cash Flow
12,624
11,975
29,651
21,288
153,243
End Cash Position
120,775
132,187
151,024
149,158
152,108
Income Tax Paid Supplemental Data
296
300
136
327
140
Issuance of Capital Stock
--
11,284
27,875
20,985
153,219
Free Cash Flow
-35,614
-30,812
-27,785
-24,238
-30,384
9/30/2021 - 4/28/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RXK3.MU SELLAS Life Sciences Group Inc
1.1490
+9.74%
SAVA.MX Cassava Sciences, Inc.
57.20
+0.12%
I9SA.HA Verona Pharma PLC
50.80
-1.93%
IPSC Century Therapeutics, Inc.
0.4905
-2.10%
IVVD Invivyd, Inc.
0.4709
-8.39%
ANVS Annovis Bio, Inc.
1.2300
+0.82%
CRDF Cardiff Oncology, Inc.
2.9060
-1.16%
CYTK Cytokinetics, Incorporated
38.97
+1.06%
SANA Sana Biotechnology, Inc.
1.5650
-7.94%
GPCR Structure Therapeutics Inc.
18.25
-3.44%